Your browser doesn't support javascript.
loading
A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.
Zhou, Xiao; Friedmann, Kim S; Lyrmann, Hélène; Zhou, Yan; Schoppmeyer, Rouven; Knörck, Arne; Mang, Sebastian; Hoxha, Cora; Angenendt, Adrian; Backes, Christian S; Mangerich, Carmen; Zhao, Renping; Cappello, Sabrina; Schwär, Gertrud; Hässig, Carmen; Neef, Marc; Bufe, Bernd; Zufall, Frank; Kruse, Karsten; Niemeyer, Barbara A; Lis, Annette; Qu, Bin; Kummerow, Carsten; Schwarz, Eva C; Hoth, Markus.
Afiliação
  • Zhou X; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Friedmann KS; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Lyrmann H; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Zhou Y; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Schoppmeyer R; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Knörck A; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Mang S; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Hoxha C; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Angenendt A; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Backes CS; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Mangerich C; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Zhao R; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Cappello S; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Schwär G; Cardiovascular Physiology, University Medical Center, University of Göttingen, Göttingen, 37073, Germany.
  • Hässig C; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Neef M; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Bufe B; Department of Theoretical Physics, Saarland University, Saarbrücken, 66041, Germany.
  • Zufall F; Physiology, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Kruse K; Physiology, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Niemeyer BA; Department of Theoretical Physics, Saarland University, Saarbrücken, 66041, Germany.
  • Lis A; Department of Biochemistry and Theoretical Physics, University of Geneva, Geneva, 1211, Switzerland.
  • Qu B; Molecular Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Kummerow C; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Schwarz EC; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
  • Hoth M; Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, 66421, Germany.
J Physiol ; 596(14): 2681-2698, 2018 07.
Article em En | MEDLINE | ID: mdl-29368348
ABSTRACT
KEY POINTS Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells are required to eliminate cancer cells. We analysed the Ca2+ dependence of CTL and NK cell cytotoxicity and found that in particular CTLs have a very low optimum of [Ca2+ ]i (between 122 and 334 nm) and [Ca2+ ]o (between 23 and 625 µm) for efficient cancer cell elimination, well below blood plasma Ca2+ levels. As predicted from these results, partial down-regulation of the Ca2+ channel Orai1 in CTLs paradoxically increases perforin-dependent cancer cell killing. Lytic granule release at the immune synapse between CTLs and cancer cells has a Ca2+ optimum compatible with this low Ca2+ optimum for efficient cancer cell killing, whereas the Ca2+ optimum for CTL migration is slightly higher and proliferation increases monotonously with increasing [Ca2+ ]o . We propose that a partial inhibition of Ca2+ signals by specific Orai1 blockers at submaximal concentrations could contribute to tumour elimination. ABSTRACT Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells are required to protect the human body against cancer. Ca2+ is a key metabolic factor for lymphocyte function and cancer homeostasis. We analysed the Ca2+ dependence of CTL and NK cell cytotoxicity against cancer cells and found that CTLs have a bell-shaped Ca2+ dependence with an optimum for cancer cell elimination at rather low [Ca2+ ]o (23-625 µm) and [Ca2+ ]i (122-334 nm). This finding predicts that a partial inhibition of Orai1 should increase (rather than decrease) cytotoxicity of CTLs at [Ca2+ ]o higher than 625 µm. We tested this hypothesis in CTLs and indeed found that partial down-regulation of Orai1 by siRNA increases the efficiency of cancer cell killing. We found two mechanisms that may account for the Ca2+ optimum of cancer cell killing (1) migration velocity and persistence have a moderate optimum between 500 and 1000 µm [Ca2+ ]o in CTLs, and (2) lytic granule release at the immune synapse between CTLs and cancer cells is increased at 146 µm compared to 3 or 800 µm, compatible with the Ca2+ optimum for cancer cell killing. It has been demonstrated in many cancer cell types that Orai1-dependent Ca2+ signals enhance proliferation. We propose that a decrease of [Ca2+ ]o or partial inhibition of Orai1 activity by selective blockers in the tumour microenvironment could efficiently reduce cancer growth by simultaneously increasing CTL and NK cell cytotoxicity and decreasing cancer cell proliferation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Linfócitos T Citotóxicos / Cálcio / Apoptose / Proliferação de Células / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Physiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Linfócitos T Citotóxicos / Cálcio / Apoptose / Proliferação de Células / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Physiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha